SLN Monoclonal Antibody
-
中文名称:SLN鼠单克隆抗体
-
货号:CSB-MA021780A0m
-
规格:¥1320
-
图片:
-
其他:
产品详情
-
产品描述:CUSABIO货号:CSB-MA021780A0m SLN单克隆抗体是针对肌集钙蛋白(Sarcolipin)靶点开发的高特异性科研试剂,该蛋白作为调节肌浆网钙ATP酶活性的关键因子,在骨骼肌和心肌细胞的钙离子稳态调控中发挥重要作用。本产品采用杂交瘤技术制备,经ELISA验证具有高亲和力,可兼容免疫组化(IHC)进行组织定位分析及流式细胞术(FC)检测细胞表面表达,适用于人类样本的蛋白质功能研究。其明确的物种特异性设计有效避免了交叉反应风险,为研究肌肉代谢机制、能量平衡调控及相关疾病模型构建提供可靠工具。在运动生理学、代谢性疾病基础研究及心肌功能探索等科研领域,该抗体可广泛应用于蛋白互作分析、亚细胞定位研究和分子信号通路解析,帮助科研人员深入探究SLN在肌细胞收缩舒张、产热调节中的分子机制。
-
产品名称:Mouse anti-Homo sapiens (Human) SLN Monoclonal antibody
-
Uniprot No.:
-
基因名:SLN
-
别名:SLN antibody; Sarcolipin antibody
-
宿主:Mouse
-
反应种属:Human
-
免疫原:Recombinant Human SLN protein (1-31AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
-
克隆类型:Monoclonal
-
抗体亚型:IgG2b
-
纯化方式:>95%, Protein G purified
-
克隆号:14G1A12
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, WB, IF, FC
-
推荐稀释比:
Application Recommended Dilution WB WB:1:1000-1:5000 IF 1:50-1:200 FC 1:50-1:200 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相关产品
靶点详情
-
功能:Reversibly inhibits the activity of ATP2A1 and ATP2A2 in sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in muscle. Required for muscle-based, non-shivering thermogenesis.
-
基因功能参考文献:
- Structure-Function Relationship of the SERCA Pump and Its Regulation by Phospholamban and Sarcolipin. PMID: 29594859
- Self-assembling study of sarcolipin and its mutants in multiple molecular dynamic simulations has been reported. PMID: 28241400
- These results suggest that sAnk1 interacts with SLN both directly and in complex with SERCA1 and reduces SLN's inhibitory effect on SERCA1 activity. PMID: 28487373
- analysis of transmembrane dynamics of the Thr-5 phosphorylated sarcolipin pentameric channel PMID: 27378083
- Phospholamban and sarcolipin are membrane proteins that differentially regulate SERCA function. (Review) PMID: 26743715
- Molecular dynamics simulations help to clarify and to understand better the SLN pentamer channel that had a hydrophobic gate and could switch Na(+) and Cl(-) ion permeability by hydrated and vacuum states. PMID: 26522287
- Although SLN and PLB binding to SERCA have different functional outcomes on the coupling efficiency of SERCA, both proteins decrease the apparent Ca(2+) affinity of the pump, suggesting that SLN and PLB inhibit SERCA by using a similar mechanism. PMID: 25983321
- SLN and PLN are co-expressed in most fibers, which suggests that super-inhibition of SERCAs may be physiologically important in the regulation of intracellular Ca2+ in human skeletal muscle. PMID: 24358354
- The C-terminal tail of SLN is a distinct, essential domain in the regulation of SERCA. PMID: 23362265
- The selective downregulation of SLN and enhanced sarcoplasmic reticulum Ca(2+) uptake in human AF suggest that SLN downregulation could play an important role in abnormal intracellular Ca(2+) cycling in atrial pathology. PMID: 21640081
- sarcolipin binds to phospholamban and inhibits polymerization PMID: 12032137
- sarcolipin is likely to be an atrial chamber-specific regulator of Ca2+ cycling in heart PMID: 12645548
- role in regulating sarco(endo)plasmic reticulum Ca2+-ATPase by binding to transmembrane helices alone or in association with phospholamban PMID: 12692302
- Gene expression of SLN was studied in children with congenital heart defects. PMID: 17515962
收起更多
-
亚细胞定位:Sarcoplasmic reticulum membrane; Single-pass membrane protein. Endoplasmic reticulum membrane; Single-pass membrane protein.
-
蛋白家族:Sarcolipin family
-
数据库链接: